Is There Any Way Out of Here? New Ideas for Funding Life Sciences Startups

Traditional means of funding private companies in the life science industry have changed forever. Venture capital is no longer a logical choice for raising capital to fund pre-clinical programs, just as it’s no long practical or acceptable to spend vast amounts of cash to advance such research. The San Diego Venture Group has assembled a panel of experienced investors to explore how companies in the life science industry can seek to accomplish their goals with—or without—traditional VC funding. Registration begins at 7 a.m., or register online here.